Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After Dosing.

CONCLUSIONS: The migraine preventive effect of eptinezumab is rapid and sustained in patients with episodic or chronic migraine, with onset of optimal preventive efficacy observed on the day following the initial dose. PMID: 33165938 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33165938?dopt=Abstract

Source: Headache - November 9, 2020 Category: Neurology Authors: Dodick DW, Gottschalk C, Cady R, Hirman J, Smith J, Snapinn S Tags: Headache Source Type: research